Multisystem Inflammatory Syndrome in Children clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

    open to eligible people ages 0-20

    The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treating provider.

    Los Angeles, California and other locations

Our lead scientists for Multisystem Inflammatory Syndrome in Children research studies include .

Last updated: